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Abstract
Background: The rate of H. pylori infection in Vietnam is reportedly high, but the spectrum of H. pylori-associated
gastroduodenal diseases has not been systematically investigated. Moreover, despite the similarities of ethnicity
and diet, the age-standardized incidence rate of gastric cancer in the northern city of Hanoi is higher than that in
the southern city of Ho Chi Minh, but the reason for this phenomenon is unknown. The virulence of Vietnamese H.
pylori has also not been investigated in detail.
Methods: Individuals undergoing esophagogastroduodenoscopy were randomly recruited. H. pylori infection status
was determined based on the combined results of culture, histology, immunohistochemistry, rapid urine test and
serum ELISA. Peptic ulcer (PU) and gastroesophageal reflux disease was diagnosed by endoscopy, and chronic
gastritis was determined histologically. H. pylori virulence factors were investigated by PCR and sequencing.
Results: Among the examined patients, 65.6% were infected with H. pylori. The prevalence of infection was
significantly higher in those over 40 years of age than in those aged ≤40. Chronic gastritis was present in all H.
pylori-infected individuals, 83.1% of whom had active gastritis, and 85.3% and 14.7% had atrophy and intestinal
metaplasia, respectively. PU was present in 21% of infected patients, whereas its incidence was very low in non-
infected individuals. The prevalence of PU was significantly higher in Hanoi than in Ho Chi Minh. The prevalence of
vacA m1, which has been identified as an independent risk factor for PU in Vietnam, was significantly higher
among H. pylori isolates from Hanoi than among those from Ho Chi Minh.
Conclusions: H. pylori infection is common in Vietnam and is strongly associated with PU, active gastritis, atrophy
and intestinal metaplasia. vacA m1 is associated with an increased risk for PU and might contribute to the
difference in the prevalence of PU and gastric cancer between Hanoi and Ho Chi Minh.
Background
Helicobacter pylori (H. pylori) is a spiral, Gram-negative
bacterium that chronically infects more than half of the
world’s population, and is currently recognized to play a
causative role in the pathogenesis of gastritis, gastroduo-
denal ulcer, gastric adenocarcinoma and mucosa-
associated lymphoid tissue (MALT) lymphoma [1,2].
Infection with H. pylori almost always results in chronic
gastritis, but more severe diseases such as peptic ulcer
and gastric cancer develop in only a small proportion of
infected patients, suggesting that the clinical outcomes
are probably determined by the interaction of bacterial
virulence, host genetic susceptibility and environmental
factors [2,3]. To date, several H. pylori virulence factors
associated with severe clinical outcomes have been
reported, including cagA, cagE, vacA, babA, oipA, iceA
and homB [4-11].
In Vietnam, the rate of H. pylori infection is report-
edly high [12], but the spectrum of H. pylori-associated
gastroduodenal diseases has not been investigated
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ethnicity and diet, the age-standardized incidence rate
(ASR) of gastric cancer in the northern city of Hanoi is
about 1.5 times higher than that in the southern city of
Ho Chi Minh (27.0 vs. 18.7 cases per 100.000 males and
13.2 vs. 8.1 cases per 100.000 females, respectively) [13],
but the reason for this intriguing phenomenon is
unknown. Additionally, the ASR of gastric cancer in
Vietnam is approximately 3 times lower than that in
Japan and Korea [13], despite the fact that the preva-
lence of H. pylori infection in Vietnam is reportedly
higher [12]. This phenomenon, regarded as an “Asian
enigma”, is thought to be partly attributable to geo-
graphic variations in bacterial virulence [14,15]. Never-
theless, the virulence of Vietnamese H. pylori strains has
not been extensively investigated. Therefore, we carried
out the present cross-sectional study to clarify these
unresolved issues.
Methods
Patients
Individuals undergoing esophagogastroduodenoscopy at
the endoscopy centers of two major hospitals in Hanoi
and Ho Chi Minh were randomly selected. Local ethics
approval and written informed consent from all partici-
pants were obtained before the study. Exclusion criteria
included a history of partial gastric resection, H. pylori
eradication therapy and treatment with antibiotics, bis-
muth-containing compounds, H2-receptor blockers or
proton pump inhibitors within 1 month before the
study. Overall, the study subjects comprised 270 partici-
pants (153 females and 117 males) aged 14 to 86 years
(mean age, 42.5 years), including 134 from Hanoi and
136 from Ho Chi Minh (Table 1).
Before endoscopy, participants were interviewed by
trained medical staff to ascertain their medical history and
lifestyle factors. During endoscopy, 5 biopsy specimens
(two from the antrum, two from the corpus and one from
the upper part of the lesser curvature) were taken and sub-
sequently used for H. pylori culture and histopathologic
examination. Peptic ulcer disease (PU) including gastric
ulcer (GU), duodenal ulcer (DU) and gastroduodenal ulcer
(GDU), and gastroesophageal reflux disease (GERD) were
diagnosed by endoscopic observation, while chronic gastri-
tis was determined histologically. After endoscopy, urine
and blood samples from all participants were collected on
the same day and tested using the rapid urine test and a
serum ELISA kit, respectively.
Determination of H. pylori infection status
To maximize the diagnostic accuracy, 5 different methods
were combined for the diagnosis of H. pylori infection,
including culture, histology, immunohistochemistry, rapid
urine test and serum ELISA.
For H. pylori culture, two biopsy specimens from the
antrum and body were homogenized in saline and
inoculated onto Mueller Hinton II Agar medium
(Becton Dickinson, NJ, USA) supplemented with 7%
horse blood without antibiotics. The plates were incu-
bated for up to 10 days at 37°C under microaerophilic
conditions (10% O2,5 %C O 2 and 85% N2). H. pylori was
identified on the basis of colony morphology, gram
staining and positive reactions for oxidase, catalase, and
urease. Isolated strains weres t o r e da t- 8 0 ° Ci nB r u c e l l a
Broth (Difco, NJ, USA) containing 10% dimethylsulf-
oxide and 10% horse serum.
HE and Giemsa staining, and immunohistochemistry
with anti-H. pylori polyclonal antibody (Dako, Denmark)
were performed using serial sections of three specimens
from the antrum, corpus and upper part of the lesser
curvature, as described previously [16]. Results were
judged by an experienced pathologist (T.U.) who was
unaware of other information about the subjects.
Table 1 Characteristics of the study population
H. pylori-
positive
H. pylori-
negative
Total
No. of participants (%) 177 (65.6%) 93 (34.4%) 270
Number (%) in region
Hanoi 89 (66.4%) 45 (33.6%) 134
Ho Chi Minh 88 (64.7%) 48 (35.3%) 136
Sex, no. (%)
Female 101 (66%) 52 (34%) 153
Male 76 (65%) 41 (35%) 117
Age group, no. (%)
≤40 67 (57.8%) 49 (42.2%) 116
≤20 6 (66.7%) 3 (33.3%) 9
21-30 24 (53.3%) 21 (46.7%) 45
31-40 37 (59.7%) 25 (40.3%) 62
> 40 110 (71.4%) 44 (28.6%) 154
41-50 62 (71.3%) 25 (28.7%) 87
51-60 30 (69.8%) 13 (30.2%) 43
>60 18 (75.0%) 6 (25.0%) 24
Mean age (range) 43.7 (14-83) 40.2 (18-86) 42.5 (14-86)
Disease
Peptic ulcer 37 1 38
Gastric cancer 0 0 0
MALT lymphoma 0 0 0
Chronic gastritis 177 68 145
Active 147 11 158
Non-active 30 57 87
Atrophy 151 53 204
Intestinal
metaplasia
26 5 31
GERD 4 5 9
Normal 0 25 25
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using the urine RAPIRUN test (Otsuka Pharmaceutical
Co., Ltd., Tokyo, Japan) and E Plate kit (Eiken Chemical
Co., Ltd., Tokyo, Japan), respectively, in accordance with
the manufacturers’ instructions.
H. pylori-positive status was determined by positive
c u l t u r eo r ,i nt h ec a s eo fn e g a t i v ec u l t u r e ,b ya tl e a s t
two positive results among the following tests: histology,
immunohistochemistry, rapid urine test and serum
ELISA. Patients were diagnosed as H. pylori-negative
when all five tests gave negative results. If only one test
other than culture was positive, patients were considered
to have undetermined H. pylori infection status and
were excluded from further analysis.
Diagnosis and scoring of chronic gastritis
Biopsy specimens were stained with HE and examined
by an experienced pathologist (T.U.). For each biopsy
specimen, the grades of neutrophil infiltration, mono-
nuclear cell infiltration, atrophy and intestinal metapla-
sia were scored on the basis of the updated Sydney
System (0, none; 1, mild; 2, moderate; and 3, severe).
Active gastritis was classified into four groups as
described previously: (i) non-active gastritis, (ii) antrum-
predominant gastritis (AP), (iii) corpus-predominant
gastritis (CP) and (iv) pangastritis (PAN) [17,18].
Investigation of H. pylori virulence factors
H. pylori was subcultured from the stock. Multiple colo-
nies on agar plates were harvested, and genomic DNA was
extracted using the standard phenol-chloroform method.
The virulence factors of H. pylori, including cagA,
cagE, vacA s/m/i, iceA, babA and homB, were examined
using PCR as described previously elsewhere
[5,7,8,19-22]. The status of oipA, “on” or “off”,w a s
determined by examining its signal sequence, as
described previously [10]. Sequencing was performed
with a Big Dye Terminator v3.1 Cycle Sequencing Kit
o naA B IP r i s m3 1 0G e n e t i cA nalyzer (Applied Biosys-
tems, CA, USA) in accordance with the manufacturer’s
instructions. All the primers used in this study were
purchased from Sigma-Aldrich Japan.
Statistical analysis
Chi-squared test, Ficher’s exact test, one-way ANOVA
test, and multivariate analysis were used. Differences at
p < 0.05 were regarded as statistically significant. Data
analysis was performed using SPSS statistical software
v.16.0 (SPSS Inc., Chicago, USA).
Results
Prevalence of H. pylori infection
Among the 270 participants, 100, 131, 133, 143 and 141 gave
positive results by culture, histology, immunohistochemistry,
rapid urine test and serum ELISA, respectively. Based
on the combined results of these tests, 177 patients
( 6 5 . 6 % )w e r ej u d g e dt ob ei n f e c t e dw i t hH. pylori,9 3
(34.4%) were H. pylori-negative, and none was consid-
ered to have undetermined H. pylori infection status
(Table 1). There was no significant difference in the
prevalence of infection between females and males
(66.0% vs. 65.0%), or between Hanoi and Ho Chi Minh
(66.4% vs. 64.7%) (Table 1). The prevalence of infec-
tion did not differ significantly among the 10-year age
groups, but was significantly higher in persons over 40
years of age than in those aged ≤40 years (71.4% vs.
57.8%, p = 0.021) (Table 1).
H. pylori infection and gastroduodenal diseases
Among the 270 participants, 38 (14.1%) were endoscopi-
cally diagnosed as having PU, including 21 DUs, 6 GUs
and 11 GDUs (DU/GU ratio, 3.5); gastric cancer and
MALT lymphoma were not detected (Table 1). The pre-
valence of PUD was 37/177 (20.9%) in the H. pylori-
infected group but only 1/93 (1.1%) in the non-infected
group (Table 1). Multivariate analysis showed that the
presence of PU was strongly associated with H. pylori
infection (adjusted OR, 27.8; 95% CI, 3.6 - 200;
p = 0.001), but not with other factors such as sex, age
group, alcohol and coffee consumption, and smoking.
The prevalence of PU was 20.1% (27/134) in Hanoi
but much lower in Ho Chi Minh, 8.1% (11/136). For H.
pylori-infected subjects, the prevalence was 30.3% (27/
89) and 11.4% (10/88) in Hanoi and Ho Chi Minh,
respectively. Multivariate analysis showed that subjects
in Hanoi had a higher risk for PU than those in Ho Chi
Minh, with an adjusted OR of 2.6 (95% CI, 1.2 - 5.9;
p = 0.02) for the overall population and 3.0 (95% CI, 1.3
- 7.0; p = 0.01) for H. pylori-infected subjects. Among
H. pylori-related PU, the proportion of GDU was signifi-
cantly higher in Hochiminh than in Hanoi. In contrast,
the proportion of GU in Hanoi appeared to be higher
than that in Hochiminh but this difference did not
reach the statistical significance (Table 2).
GERD was diagnosed endoscopically in 9 cases (3.3%)
and was not inversely associated with H. pylori infection
status (p = 0.282).
H. pylori infection and chronic gastritis
Chronic gastritis was present in all H. pylori-infected
persons, the majority of whom (147/177, 83.1%) had
active gastritis, including AP (57.1%), CP (3.4%) and
PAN (22.6%). Atrophic gastritis had developed in the
majority of them (151/177, 85.3%), even in younger indi-
viduals, and its prevalence appeared to increase with age
(Figure 1). About 14.7% (26/177) of infected persons
had intestinal metaplasia, which was always accompa-
nied by atrophy (Table 1 and Figure 1). The prevalence
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infected patients was significantly lower in Hanoi than
in Hochiminh, whereas the prevalence of pangastritis in
Hanoi was significantly higher than that in Hochiminh.
However, there was no significant difference in the pre-
valences of atrophy and intestinal metaplasia between
the two cities (Table 2).
Multivariate analysis showed that H. pylori positivity
was strongly associated with active inflammation
(adjusted OR, 41.7; 95% CI, 18.9 - 90.9; p < 0.001),
chronic inflammation (adjusted OR, 19.2; 95% CI,
5.5 - 66.7; p < 0.001), atrophy (adjusted OR, 4.2; 95%
CI, 2.3 - 7.7; p < 0.001) and intestinal metaplasia
(adjusted OR, 3.2; 95% CI, 1.1 - 9.8; p = 0.036) in the
gastric mucosa. An age of >40 years conferred an
increased risk for atrophy (adjusted OR, 3.0; 95% CI, 1.6
- 5.5; p < 0.001) and intestinal metaplasia (adjusted 3.1;
95% CI, 1.2 - 7.9; p = 0.02).
H. pylori virulence factors and peptic ulcer
An important focus of our interest was why the preva-
lence of PU was significantly higher in Hanoi than in
Ho Chi Minh. It is currently accepted that the clinical
outcomes of H. pylori infection are determined by the
interaction of bacterial virulence, and host and environ-
mental factors. Because the ethnicity, environmental
factors and prevalence of H. pylori infection in the two
regions are similar, we focused on bacterial virulence.
We investigated genetic factors of H. pylori that are
reportedly associated with gastroduodenal diseases,
including cagA, cagE, vacA (s/m/i), babA, oipA, iceA,
and homB, in 100 clinical strains (53 from Hanoi and 47
from Ho Chi Minh), of which 24 and 76 strains were
isolated from patients with PU and chronic gastritis,
respectively. Details of the results are presented in Table 3.
Multivariate analysis showed that only vacA m1 was
an independent risk factor for PU (adjusted OR, 3.0;
95% CI, 1.1 - 8.4; p = 0.034). Moreover, infection with
H. pylori that simultaneously possessed vacA m1
together with cagA, cagE and babA (quadruple positiv-
ity) conferred an increased risk for PU (OR, 4.2; 95%
CI, 1.5 - 11.3, p = 0.005). Interestingly, the prevalences
of vacA m1 and quadruple positivity were significantly
higher among H. pylori isolates from Hanoi than
among those from Ho Chi Minh (58.5% vs. 36.2%,
p = 0.029 and 54.7% vs. 34.0%, p = 0.046, respectively)
(Table 4). In addition, comparison of virulence factors of
Table 2 Clinical outcomes among H. pylori-infected
patients in Hanoi and Hochiminh
Disease Hanoi
(n = 89)
Hochiminh
(n = 88)
p
Peptic ulcer 27 (30.3%) 10 (11.4%) < 0.05
Duodenal ulcer 19 2 N.S
Gastric ulcer 6 0 N.S
Gastroduodenal ulcer 2 8 < 0.05
Chronic gastritis 89 (100%) 88 (100%) N.S
Active gastritis 70 (78.7%) 77 (87.5%) N.S
Antrum-predominant
gastritis
42 59 < 0.05
Corpus-predominant
gastritis
3 3 N.S
Pangastritis 25 15 < 0.05
Atrophy 76 (85.4%) 75 (85.2%) N.S
Intestinal metaplasia 15 (16.9%) 11 (12.5%) N.S
N.S, not significant
Figure 1 Prevalence of gastric atrophy and intestinal metaplasia among H. pylori-infected Vietnamese by age group.
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cant difference (data not shown).
Discussion
We found that the prevalence of H. pylori infection in
Vietnam was about 66%, being somewhat similar to that
in several other Asian countries [12]. In this study, H.
pylori infection was proved to be strongly associated with
active gastritis, atrophy, intestinal metaplasia, and espe-
cially PU (adjusted OR, 27.8; p = 0.001). We did not detect
any case of gastric cancer or MALToma, possibly due to
their low prevalence and the small sample size. H. pylori is
probably a very important cause of PU in Vietnam, as PU
was observed in approximately 21% of infected patients,
while it was virtually absent in non-infected subjects.
We discovered that the majority of H. pylori isolates
from Vietnam possessed cagA, cagE, babA, oipA “on”,
vacA s1 and vacA i1, while other genes such as vacA
m1, homB and iceA1 were less frequent. Among these
virulence factors, only vacA m1 w a si d e n t i f i e da sa n
independent risk factor for PU (adjusted OR, 3.0).
Moreover, the co-existence of vacA m1 with cagA, cagE
and babA conferred an increased risk for PU, perhaps
due to a synergic effect among them. Current evidence
indicates that the ASR of gastric cancer in Hanoi is
about 1.5 times higher than that in Ho Chi Minh [13],
and this appeared to accord with the differences
Table 3 Virulence factors of H. pylori from Vietnam
Total
(n =
100)
Peptic
ulcer
(n = 24)
Chronic
gastritis
(n = 76)
p
cagA > 0.05
Positive 95 (95%) 24 (100%) 71 (93.4%)
Negative 5 (5%) 0 (0%) 5 (6.6%)
cagE > 0.05
Positive 88 (88%) 24 (100%) 64 (84.2%)
Negative 12 (12%) 0 (0%) 12 (15.8%)
vacA m † < 0.05
m1 48 (48%) 17 (70.8%) 31 (40.8%)
m2 52 (52%) 7 (29.2%) 45 (59.2%)
vacA s > 0.05
s1 100
(100%)
24 (100%) 76 (100%)
s2 0 (0%) 0 (0%) 0 (0%)
vacA i > 0.05
i1 94 (94%) 24 (100%) 70 (92.1%)
i2 6 (6%) 0 (0%) 6 (7.9%)
babA > 0.05
Positive 92 (92%) 24 (100%) 68 (89.5%)
Negative 8 (8%) 0 (0%) 8 (10.5%)
oipA status > 0.05
On 100
(100%)
24 (100%) 76 (100%)
Off 0 (0%) 0 (0%) 0 (0%)
iceA > 0.05
iceA1 50 (50%) 13 (54.2%) 37 (48.7%)
iceA2 44 (44%) 11 (45.8%) 33 (43.5%)
Both iceA1/2 3 (3%) 0 (0%) 3 (3.9%)
None 3 (3%) 0 (0%) 3 (3.9%)
homB > 0.05
Positive 39 (39%) 7 (29.2%) 32 (42.1%)
Negative 61 (61%) 17 (70.8%) 44 (57.9%)
Quadruple positivity † < 0.05
Yes 45 (45%) 17 (70.8%) 28 (36.8%)
No 55 (55%) 7 (29.2%) 48 (63.2%)
† Prevalence was significantly different between peptic ulcer and chronic
gastritis
Table 4 Prevalence of H. pylori virulence factors in Hanoi
and Ho Chi Minh
Hanoi
(n = 53)
Ho Chi Minh
(n = 47)
p (Hanoi vs. Ho Chi
Minh)
cagA N.S
Positive 51 (96.2%) 44 (93.6%)
Negative 2 (3.8%) 3 (6.4%)
cagE N.S
Positive 49 (92.5%) 39 (83.0%)
Negative 4 (7.5%) 3 (6.4%)
vacA m 0.034
m1 31 (58.%) 17 (36.2%)
m2 22 (41.5% 30 (63.8%)
vacA s N.S
s1 53 (100%) 48 (100%)
s2 0 (0%) 0 (0%)
vacA i N.S
i1 50 (94.3%) 44 (93.6%)
i2 3 (5.7%) 3 (6.4%)
babA N.S
Positive 50 (94.3%) 42 (89.4%)
Negative 3 (5.7%) 5 (10.6%)
oipA status N.S
On 53 (100%) 48 (100%)
Off 0 (0%) 0 (0%)
iceA N.S
iceA1 26 (49.1%) 24 (51.1%)
iceA2 23 (43.4%) 21 (44.7%)
Both
iceA1/2
2 (3.8%) 1 (2.1%)
None 2 (3.8%) 1 (2.1%)
homB N.S
Positive 19 (35.8%) 20 (42.6%)
Negative 34 (64.2%) 27 (57.4%)
Quadruple
positivity
0.046
Yes 29 (54.7%) 16 (34.0%)
No 24 (45.3%) 31 (66.0%)
N.S, not significant.
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predominant gastritis and pangastritis. Moreover, in the
present study the prevalence of PU in Hanoi was also
proved to be significantly higher. Our results suggest
that the higher prevalence of PU in Hanoi might be
attributable to the higher prevalence of H. pylori strains
carrying vacAm1 and quadruple positivity in Hanoi, in
comparison with Ho Chi Minh. Because H. pylori viru-
lence was associated with both PU and gastric cancer,
our data, although not direct, are the first to indicate a
reason for the difference in the ASR of gastric cancer
between these two regions of Vietnam.
Compared with Japan, the ASR of gastric cancer in Viet-
nam is much lower [13], and this seems to be reflected by
the DU/GU ratio as well as the pattern of chronic gastritis
observed in Vietnamese patients. The DU/GU ratio has
been regard as a good marker for evaluating the risk of
gastric cancer in certain populations because DU patients
have low risk of developing gastric cancer whereas the
opposite is true for GU patients [18,23]. The DU/GU ratio
in Vietnam is about four times higher than that in Japan,
but still much lower than that in India, where the ASR of
gastric cancer is very low [13,23]. Corresponding well to
the high DU/GU ratio, the majority of infected Vietna-
mese have antrum-predominant gastritis (57%) whereas
the rate of corpus-predominant gastritis is low (3.4%) in
comparison with Japan (14~17%) [17,18].
Because H. pylori virulence is thought to contribute
partly to the geographic variation in the ASR of gastric
cancer [14,15], we compared various virulence factors of
Vietnamese strains with those of Japanese ones. From the
literature, it is evident that nearly all Japanese H. pylori
strains simultaneously carry cagA, cagE, vacAm1/s1/i1,
babA and oipA “on” [6,10,11,22,24], while among Vietna-
mese strains, this figure is around 45%. Furthermore, the
prevalence of homB-positive strains is also higher in
Japan than in Vietnam (over 90% vs. 39%) [8,25]. From
these data, it is tempting to speculate that the difference
in ASR of gastric cancer is attributable partly to the
difference in bacterial virulence between the two countries.
Conclusions
Our study indicates that H. pylori infection is common
in Vietnam and is strongly associated with the develop-
ment of PU, active gastritis, atrophy and intestinal meta-
plasia. Moreover, H. pylori vacA m1 is associated with
an increased risk for PU and might contribute to the
difference in the prevalence of PU and gastric cancer
between Hanoi and Ho Chi Minh.
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